| Product Code: ETC7653215 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Hemostatic Agents Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Hemostatic Agents Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Hemostatic Agents Market - Industry Life Cycle |
3.4 Israel Hemostatic Agents Market - Porter's Five Forces |
3.5 Israel Hemostatic Agents Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Israel Hemostatic Agents Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Hemostatic Agents Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing number of surgical procedures in Israel, leading to higher demand for hemostatic agents. |
4.2.2 Rising prevalence of chronic diseases in the country, necessitating the use of hemostatic agents during treatments. |
4.2.3 Technological advancements in hemostatic agents, making them more effective and safer for use in medical procedures. |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval and commercialization of hemostatic agents, leading to delays in market entry. |
4.3.2 High cost associated with advanced hemostatic agents, limiting their adoption in certain healthcare settings. |
5 Israel Hemostatic Agents Market Trends |
6 Israel Hemostatic Agents Market, By Types |
6.1 Israel Hemostatic Agents Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Hemostatic Agents Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Israel Hemostatic Agents Market Revenues & Volume, By Active Agents, 2021- 2031F |
6.1.4 Israel Hemostatic Agents Market Revenues & Volume, By Passive Agents, 2021- 2031F |
6.1.5 Israel Hemostatic Agents Market Revenues & Volume, By Combination, 2021- 2031F |
6.2 Israel Hemostatic Agents Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Israel Hemostatic Agents Market Revenues & Volume, By Large Hospital (500+ Beds), 2021- 2031F |
6.2.3 Israel Hemostatic Agents Market Revenues & Volume, By Medium Hospital (250-499 Beds), 2021- 2031F |
6.2.4 Israel Hemostatic Agents Market Revenues & Volume, By Small Hospitals (Less than 250 Beds), 2021- 2031F |
7 Israel Hemostatic Agents Market Import-Export Trade Statistics |
7.1 Israel Hemostatic Agents Market Export to Major Countries |
7.2 Israel Hemostatic Agents Market Imports from Major Countries |
8 Israel Hemostatic Agents Market Key Performance Indicators |
8.1 Average length of hospital stay post-surgery, indicating the effectiveness of hemostatic agents in reducing bleeding complications. |
8.2 Number of new product launches in the hemostatic agents market, reflecting innovation and market growth. |
8.3 Adoption rate of minimally invasive surgical procedures, as hemostatic agents play a crucial role in these techniques. |
9 Israel Hemostatic Agents Market - Opportunity Assessment |
9.1 Israel Hemostatic Agents Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Israel Hemostatic Agents Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Hemostatic Agents Market - Competitive Landscape |
10.1 Israel Hemostatic Agents Market Revenue Share, By Companies, 2024 |
10.2 Israel Hemostatic Agents Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |